Japan Bioanalysis Forum

Learn how Q2 Solutions can accelerate and enhance your discovery, preclinical and clinical programs

Tokyo, Japan | February 06, 2018 - February 08, 2018 | 08:00 - 17:00 Add to Calendar
Register to Receive Presentation Schedule a Meeting

About This Event

Q2 Solutions’ Senior Scientific Director of Bioanalysis and ADME services, Steve Lowes, will be presenting at the Japan Bioanalysis Forum, which takes place in Tokyo February 6th-8th.

Make plans to attend his presentation February 7th, which will focus on validating LC/MS bioanalytical methods for protein therapeutics.

Q2 Solutions is one of the few bioanalytical laboratories successfully employing immunoprecipitation techniques and multi-dimensional liquid chromatography for the quantitation of biotherapeutics, peptides, proteins, and biomarkers.

Our scientists have extensive expertise in bioanalytical testing, method development and liquid chromatography – tandem mass spectrometry to not only meet your analytical needs but to bring insights to the table that enhance the drug development process.

Schedule a meeting with Steve on-site to learn more about our bioanalytical capabilities, including our biomarker services and validated bioanalytical methods list.

Related Services:


Stephen Lowes, Ph.D.
Senior Scientific Director, Small Molecule PK

Prior to joining Q2 Solutions in 2011, Dr. Lowes was an executive management scientific leader of Advion BioServices. Dr. Lowes started his industrial career at VG Biotech in the UK that became the LC/MS instrument entity of Waters Corporation. In 1995 Dr. Lowes joined the CRO group that became Advion and focused his career on regulated bioanalysis with particular emphasis on LC/MS. He has remained very connected on regulatory developments in bioanalysis and is a founding member of the Global Bioanalysis Consortium (GBC) and a past-chair of the AAPS Bioanalytical Focus Group.

At Q2 Solutions, Dr. Lowes leads the scientific disciplines around LC/MS bioanalysis for both small molecule and biomolecule applications including biomarker assays.  Dr. Lowes has more than 40 peer reviewed publications on bioanalysis and is a frequent speaker at national and international conferences. 

Dr. Lowes earned his Ph.D. in analytical chemistry from the Open University, United Kingdom.

Updated as of September 2018.

Mass Spectrometry to Enable Sensitive Quantitation of a Small Molecule Therapeutic

Overcoming Triple Quadrupole Selectivity Challenges by Use of High-Resolution Accurate Mass Spectrometry to Enable Sensitive Quantitation of a Small Molecule Therapeutic in Rabbit Plasma

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Immunogenicity Testing in Biologics R&D: Whats your strategy?

Read More